{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:02:45Z","timestamp":1789322565498,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Interferon-beta (IFN-\u03b2) is a cytokine with a wide range of biological and pharmaceutical applications, including multiple sclerosis (MS), cancer, some autoimmune disorders, and viral infectious diseases. Thus, many studies have been performed to develop novel strategies for the high-yield production of functional IFN-\u03b2 in a cost-effective approach. Here, we aimed to improve the intracellular expression of IFN-\u03b2-1a in\n                      <jats:italic toggle=\"yes\">Pichia pastoris<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The gene of IFN-\u03b2-1a was successfully sub-cloned into the pPICZA vector. The recombinant vector was transfected to\n                      <jats:italic toggle=\"yes\">P. pastoris<\/jats:italic>\n                      GS115 cells by electroporation. After screening positive\n                      <jats:italic toggle=\"yes\">P. pastoris<\/jats:italic>\n                      transformants, the expression of IFN-\u03b2-1a was evaluated and the cultivation conditions, including temperature, time of incubation, and methanol concentration, were optimized. The protein expression levels were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The double digestion with\n                      <jats:italic toggle=\"yes\">Eco<\/jats:italic>\n                      RI and\n                      <jats:italic toggle=\"yes\">Xho<\/jats:italic>\n                      I restriction enzymes and sequence analysis confirmed the correct sub-cloning of the IFN-\u03b2-1a gene into pPICZA. SDS-PAGE analysis showed that the highest level of IFN-\u03b2-1a (25 mg per 1 L of yeast culture) was produced with 2% methanol at 28\u00b0C after 72 h incubation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Optimization of cultivation conditions for intracellular expression of IFN-\u03b2-1a was successfully performed. This approach can be generally applied to improve the production yield and quality of other recombinant proteins in\n                      <jats:italic toggle=\"yes\">P. pastoris<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_376_23","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:04:31Z","timestamp":1724817871000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cloning and Optimization of Intracellular Expression of Human Interferon \u03b2-1a in Pichia pastoris GS115"],"prefix":"10.4103","volume":"13","author":[{"given":"Diba","family":"Saeidi","sequence":"first","affiliation":[{"name":"Pharmacy Student Research Committee, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saeidi","sequence":"additional","affiliation":[{"name":"Pharmacy Student Research Committee, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moazen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajihe","family":"Akbari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00253-006-0465-8","article-title":"Overview of bacterial expression systems for heterologous protein production: From molecular and biochemical fundamentals to commercial systems","volume":"72","author":"Terpe","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sbi.2014.03.006","article-title":"Better and faster: Improvements and optimization for mammalian recombinant protein production","volume":"26","author":"Almo","year":"2014","journal-title":"Curr Opin Struct Biol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-420070-8.00012-X","article-title":"Protein expression-yeast","volume":"536","author":"Nielsen","year":"2014","journal-title":"Methods Enzymol"},{"key":"R8-20240830","first-page":"17","article-title":"Systems biotechnology for protein production in Pichia pastoris","author":"Zahrl","year":"2017","journal-title":"FEMS Yeast Res"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"e18984","DOI":"10.1590\/s2175-97902022e18984","article-title":"Bioprocess optimization of interferon \u03b2-1-a in Pichia pastoris and its improved inhibitory effect against hepatocellular carcinoma cells","volume":"58","author":"Moatamedi","year":"2022","journal-title":"Braz J Pharm Sci"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00253-005-0018-6","article-title":"Process optimization of constitutive human granulocyte-macrophage colony-stimulating factor (hGM-CSF) expression in Pichia pastoris fed-batch culture","volume":"69","author":"Pal","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"e0233492","DOI":"10.1371\/journal.pone.0233492","article-title":"Constructing a human complex type N-linked glycosylation pathway in Kluyveromyces marxianus","volume":"15","author":"Lee","year":"2020","journal-title":"PLOS One"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1059777","DOI":"10.3389\/fmicb.2022.1059777","article-title":"Current advances of Pichia pastoris as cell factories for production of recombinant proteins","volume":"13","author":"Pan","year":"2022","journal-title":"Front Microbiol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1038\/s41467-019-10903-9","article-title":"IFN-\u03b2 is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation","volume":"10","author":"Kumaran","year":"2019","journal-title":"Nature Commun"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00210-021-02061-x","article-title":"Interferon-beta offers promising avenues to COVID-19 treatment: A systematic review and meta-analysis of clinical trial studies","volume":"394","author":"Nakhlband","year":"2021","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons \u03b1 and \u03b2 in cancer: Therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.enzmictec.2007.09.006","article-title":"High level production and purification of human interferon \u03b12b in high cell density culture of Pichia pastoris","volume":"42","author":"Ayed","year":"2008","journal-title":"Enzyme Microb Technol"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.procbio.2016.02.007","article-title":"Improving the production of human interferon gamma (hIFN-\u03b3) in Pichia pastoris cell factory: An approach of cell level","volume":"51","author":"Prabhu","year":"2016","journal-title":"Process Biochem"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1002\/jcp.29583","article-title":"Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins","volume":"235","author":"Karbalaei","year":"2020","journal-title":"J Cell Physiol"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biotechadv.2017.11.002","article-title":"Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris: A review","volume":"36","author":"Yang","year":"2018","journal-title":"Biotechnol Adv"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12010-015-1590-6","article-title":"Improving performance and operational stability of porcine interferon-\u03b1 production by pichia pastoris with combinational induction strategy of low temperature and methanol\/sorbitol co-feeding","volume":"176","author":"Gao","year":"2015","journal-title":"Appl Biochem Biotechnol"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/pr8007623","article-title":"The effect of temperature on the proteome of recombinant Pichia pastoris","volume":"8","author":"Dragosits","year":"2009","journal-title":"J Proteome Res"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/BA20030065","article-title":"Expression and characterization of human interferon-beta1 in the methylotrophic yeast Pichia pastoris","volume":"38","author":"Skoko","year":"2003","journal-title":"Biotechnol Appl Biochem"},{"key":"R24-20240830","first-page":"29","article-title":"Effect of methanol induction and incubation TIME on expression of human erythropoietin in methylotropic yeast pichia pastoris","volume":"16","author":"Adi","year":"2012","journal-title":"Makara J Technol"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_376_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:49Z","timestamp":1787771449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_376_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"URL":"https:\/\/doi.org\/10.4103\/abr.abr_376_23","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2023-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}